20/20 GeneSystems, Inc.

14 articles about 20/20 GeneSystems, Inc.

•  20/20 GeneSystems To Provide Newly FDA Authorized COVID-19 Antibody Blood Test

  5/18/2020

  20/20 GeneSystems, Inc. announced today that it will offer in its CLIA laboratory a COVID-19 antibody test that received an Emergency Use Authorization (EUA) from the FDA on May 3.

• 20/20 BioResponse to Launch Rapid Coronavirus Test Kits in U.S. following “Green Light” from FDA

  3/19/2020

  Rapid Antibody Test Generates Results in under 15 minutes from Blood Drop without Laboratory Equipment or Personnel

• 20/20 GeneSystems Announces HSR Clearance For Collaboration And License Agreement With Momenta

  2/17/2017

• 20/20 GeneSystems Nabs $4.5 Million, Eyes IPO

  2/16/2016

• Study Shows Use Of 20/20 GeneSystems, Inc.’ Breast Cancer Indexsm Molecular Test Substantially Lowers Medical Costs For ER+ Breast Cancer Patients Compared With Standard Management

  9/11/2014

• Bao Hao Investment Management Co. Affiliate Takes Equity Stake In 20/20 GeneSystems, Inc.

  8/21/2014

• 20/20 GeneSystems, Inc. on Hunt for $5 Million to Broaden Lung Cancer Diagnostic’s Market, Launch in Kidney Cancer, CEO Says

  5/20/2013

• 20/20 GeneSystems, Inc. Announces the Appointment of Joel Kanter, Chairman of the Board, and Two Additional Board Members Raymond Cypess, DVM/Ph.D. and Lawrence Shulman, Esq.

  3/18/2013

• 20/20 GeneSystems, Inc. Awarded $3 Million from National Cancer Institute to Develop Personalized Medicine Tests

  10/19/2010

• 20/20 GeneSystems, Inc. Awarded $3 Million from National Cancer Institute to Develop Personalized Medicine Tests

  10/19/2010

• 20/20 GeneSystems, Inc. Release: New Multiplex Tissue Biomarker Technology Launched to Advance Personalized Medicine

  9/14/2010

• 20/20 GeneSystems, Inc. Licenses Lung Cancer Blood Test to Ortho-Clinical Diagnostics

  1/17/2008

• National Institute of Standards and Technology Awards $2 Million to 20/20 GeneSystems, Inc. for Innovative Tumor Profiling Technology

  10/5/2007

• 20/20 GeneSystems, Inc.'s Blood Test Predicts Detects Lung Cancer Years Before CT Scan

  8/1/2006